Ziccum AB Sustainability Reports
Ziccum AB develops patented ambient drying and formulation technologies for biopharmaceuticals and vaccines. Its proprietary LaminarPace technology transforms delicate liquid biologics into thermostable dry powders without heat stress.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 5493005TADJBZHXP0U27
1 reports from 2021 to 2021
Company Profile
Ziccum AB develops patented ambient drying and formulation technologies for biopharmaceuticals and vaccines. Its proprietary LaminarPace technology transforms delicate liquid biologics into thermostable dry powders without heat stress.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years